Uneasy alliance—clinical investigators and the pharmaceutical industry

Cited by (641)

Items 401–500 of 641

1. Asthma, atopy and COPD in sub-Saharan countries: the challenges.
   S. Musafiri, G. Joos, J. V. van Meerbeeck · 2011 · East African Journal of Public Health
2. Conflicts of interest in medical practice.
   J. Antunes · 2007 · Advances and technical standards in neurosurgery
3. Reported Outcomes in Major Cardiovascular Clinical Trials Funded by For-Profit and Not-for-Profit Organizations: 2000–2005Ridker PM, Torres J (Harvard Med School) JAMA 295:2270–2274, 2006§
   W. Frishman · 2007 · Yearbook of Medicine
4. Pharmaceutical Industry Support of Psychiatric Research and Education: Ethical Issues and Proposed Remedies
   C. Goldman, D. Cutler · 2002 · Kluwer Academic Publishers eBooks
5. Conflicts of interest in medicine: understanding the concepts to preserve the integrity of professional judgement and promote trust in the profession
   T. Thirumoorthy · 2023 · Singapore medical journal
6. Bayesian persuasion with optimal learning
   Xiao-Ye Liao · 2021
7. Success in Academic Surgery: Clinical Trials
   T. Pawlik, J. Sosa · 2014
8. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
   F. Alfonso, Adam D. Timmis, F. Pinto, G. Ambrosio, H. Ector, P. Kułakowski, P. Vardas · 2012 · Arquivos Brasileiros de Cardiologia
9. Animal Models in Cardiovascular MRI Research: Value and Limitations
   B. A. French · 2012 · Current Cardiovascular Imaging Reports
10. Commercialism, loss of professionalism, and the effect on journals.
    T. Liesegang · 2008 · A M A Archives of Ophthalmology
11. Ethical issues concerning therapeutic studies in inflammatory bowel disease
    W. Tremaine, M. Camilleri · 2007 · Inflammatory Bowel Diseases
12. Explicitan los autores de la Revista Médica de Chile sus fuentes de financiamiento
    G. WilliamRomero, Sofía P. Salas · 2007
13. The Society for Academic Emergency Medicine position on ethical relationships with the biomedical industry.
    R. Schears, Andy Watters, T. Schmidt, C. Marco, G. Larkin, J. Marshall, J. Mason, B. McBeth, M. Mello · 2007 · Academic Emergency Medicine
14. A profitable new definition of health
    S. Myers, M. Stafford · 2007
15. The profession and the pharmaceutical industry.
    C. Koblenzer · 2005 · Clinical Dermatology
16. ACQUIRED COLOR BLINDNESS IN AN ELDERLY MALE PATIENT FROM RECURRENT METASTATIC PROSTATE CANCER
    David G. Harper, E. Arsura, R. Bobba, C. Reddy, Amar K. Sawh · 2005 · Journal of The American Geriatrics Society
17. Intellectual property and the commercialization of research and development
    Vincent di Norcia · 2005
18. Pharmaceutical companies and ophthalmic research.
    T. Liesegang, A. Schachat, D. Albert · 2005 · Ophthalmology (Rochester, Minn.)
19. Public welfare agenda or corporate research agenda?
    Ajai R Singh, ShakuntalaA Singh · 2005 · Mens Sana monographs
20. Editorials: Ethical Conflicts for Physicians Treating ESRD Patients
    William M. Bennett · 2004 · Seminars in dialysis
21. Management of academic health centers: The past, present, and future
    Sharon Topping, Donna M. Malvey · 2004 · Advances in health care management
22. Commentary: how the doctor can counter commercial bias in the dissemination of pharmacotherapeutic knowledge.
    W. Carpenter · 2002 · Journal of Nervous and Mental Disease
23. Control participants of randomised trials: an often forgotten, vulnerable population.
    G. R. Mohyuddin, N. Mehra, B. Ryll, Vinay Prasad · 2022 · The Lancet Haematology
24. Clinical trials in otology: Examining trends and framework for prioritization
    J. Altshuler, Rohan Viswanathan, Divya B. Dasani, Katherine L. Webb, Tam Ramsey, Varun Patel, Randall Ruffner, J. Mouzakes, D. Foyt · 2020 · Journal of Otology
25. Industry-funded clinical trials: Beneficial or harmful?
    Jing Zhang, Yiping Yuan · 2015 · Clinical Research and Regulatory Affairs
26. Nutrigenomics, Mass Media and Commercialization Pressures
    T. Bubela, Ben Taylor · 2014 · DigitalGeorgetown (Georgetown University Library)
27. Unfulfilled translation opportunities in industry sponsored clinical trials
    Marie Smed, Kenneth A. Getz · 2013 · Contemporary Clinical Trials
28. More Regulation of Industry-Supported Biomedical Research: Are We Asking the Right Questions?
    S. Fry-Revere, D. Malmstrom · 2009 · Journal of Law, Medicine & Ethics
29. An analysis of the clinical development of drugs in Norway for the years 2000 and 2004: the influence of the pharmaceutical industry
    F. Winther, O. P. Hole, S. Nitter-Hauge · 2007 · European Journal of Clinical Pharmacology
30. Invasion of the Body Snatchers: Prescription Privileges, Professional Schools, and the Drive to Create a New Behavioral Health Profession
    S. Hayes, Grace Chang · 2006 · Clinical Psychology Science and Practice
31. Informed Consent for Therapy and Research in Continuous Renal Replacement Therapy: An International Survey
    N. Zamperetti, R. Bellomo, Claudio Ronco, I. Bolgan, Z. Ricci · 2006 · International Journal of Artificial Organs
32. “Real world” study of antipsychotic effectiveness for chronic inpatients with schizophrenia in a state psychiatric hospital: Preliminary results and commentary
    J. Comaty, C. Advokat · 2006
33. What? Influenced by industry? Not me!
    M. Mahowald, M. C. Cramer Bornemann · 2005 · Sleep Medicine
34. Protection of children and adolescents in psychiatric research: an unfinished business.
    A. Solyom, J. Moreno · 2005 · HEC Forum
35. RESPONSE LETTER TO DR. ASHGAR ALI
    Lori B. Frank, Leah Kleinman · 2005
36. Ethical dilemmas encountered during clinical drug trials.
    G. Daikos · 2004 · International Journal of Antimicrobial Agents
37. Ensayos clnicos, buena prctica de publicacin y regulaciones legislativas
    V. Alfaro · 2004
38. Towards a European Network for Multiple Sclerosis Trials (ENMST)
    L. Kappos, C. Polman, Alan J. Thompson, P. Duda, M. Clanet, G. Comi, H. Hartung, X. Montalbán · 2003 · Multiple Sclerosis
39. Pharmaceutical industry's barriers and preferences to conduct clinical drug trials in Finland: a qualitative study.
    T. Keinonen, T. Keränen, T. Klaukka, V. Saano, P. Ylitalo, H. Enlund · 2003 · European Journal of Pharmaceutical Sciences
40. Research ethics - revisited
    E. Meland · 2003 · Scandinavian Journal of Primary Health Care
41. Scientific data from clinical trials: Investigators responsibilities and rights
    H. Polk, T. Bowden, L. Rikkers, C. Balch, C. Organ, J. Murie, W. Pories, M. Buechler, J. Neoptolemos, V. Fazio et al. · 2002 · World Journal of Surgery
42. Evidence‐based Practice: Assessing the Quality of the Evidence Part II: Grading the Evidence
    F. Chung, Darlene Reid · 2001
43. Preventive health care for an endangered species--the physician scientist.
    R. Badaró, Thomas C. Jones · 2001 · Brazilian Journal of Infectious Diseases
44. If daily dialysis is the answer, what is the question?
    R. Rettig · 2001 · American Journal of Kidney Diseases
45. Building the relationship between industry and academia: Benefits and the general landscape of accomplishing research
    J. Fogt, Kitzmiller Jp · 2017
46. Ethical Issues in Psychiatry in Southeast Asia: Research and Practice
    S. Math, B. Viswanath, A. S. Maroky · 2015 · International library of ethics, law, and the new medicine/The international library of ethics, law, and the new medicine
47. A View from Inside: Regulation and Ethical Conflicts in Peru
    Gabriela Emperatriz Minaya-Martínez, Susy Y. Olave-Quispe, D. Fuentes-Delgado · 2014
48. Biomedicine and the Human Condition
    Michael G. Sargent · 2005 · Cambridge University Press eBooks
49. Exploring Ethical, Moral, and Legal Issues Related to Kidney Diseases
    D. Levine · 2001 · American Journal of Kidney Diseases
50. Systematic reviews: Not always a pain
    A. Fogarty, Aaron M. Conger, Taylor Burnham · 2022 · Interventional Pain Medicine
51. An Archeology of Corruption in Medicine
    M. Little, W. Lipworth, I. Kerridge · 2022 · Journal of Bioethical Inquiry
52. Nonalcoholic Steatohepatitis, Peroxisome Proliferator-Activated Receptors and Our Good Glitazar: Proof of the Pudding is in the Eating.
    A. C. Anand, S. Acharya · 2022 · Journal of Clinical and Experimental Hepatology
53. Conflicts of Interest Among Authors of Systematic Reviews Regarding the Management of Chronic Non-Cancer Pain with Opioids Analgesics
    Connor Polson, Parker Siex, Jon Michael Anderson, Michael Weaver, Will Roberts, Micah L. Hartwell, Matt B. Vassar · 2021 · Pain Medicine
54. Emergency physicians can be leaders in clinical innovation: Tips to JumpStart the engine.
    David C. Sheridan, O. Ma, M. Hansen · 2019 · American Journal of Emergency Medicine
55. Allergen immunotherapy: exploring areas for further inquiry
    Tam Ramsey, Wanda Lai, Peter F. Svider, Houmehr Hojjat, J. Eloy, A. Folbe · 2017 · International Forum of Allergy and Rhinology
56. Research funding: do you get what you pay for?
    P. B. Persson, A. B. Persson · 2017 · Acta Physiologica
57. S/he blinded me with science: the sociology of scientific misconduct
    James N. Baron, M. King, O. Sorenson · 2016 · Cambridge University Press eBooks
58. Conflict of Interest in Research--The Clinician Scientist's Perspective.
    N. Y. Kong, P. Chow · 2013 · Annals of the Academy of Medicine, Singapore
59. Social Studies of Science
    Philip Mirowski, R. V. van Horn · 2013
60. Key Aspects of Physician and Pharmaceutical Industry Relationships for Trainees
    Shaili Jain · 2010 · Academic Psychiatry
61. Safety in Human Research: Past Problems and Current Challenges from a Canadian Perspective
    B. Schwartz · 2008 · HEC Forum
62. Evaluating Quality in Clinical Cancer Research: The M.D. Anderson Cancer Center Experience
    J. Cox, S. Giralt, Mary L Veazie, J. Ajani, J. Bruner, Ka-Wah Chan, W. Hittelman, K. Hunt, R. Iyer, D. Karp et al. · 2008 · Oncology
63. Marketing Off-Label Uses to Physicians: FDA's Draft (Mis)Guidance
    Andy Gass, Jennifer G. Wilson · 2008 · American Journal of Bioethics
64. Un método para cuantificar las contribuciones de los colaboradores en las publicaciones científicas
    Santiago Guallar · 2007 · Animal Biodiversity and Conservation
65. Bioethical Issues in Medicinal Chemistry and Drug Treatment
    P. Wolpe, M. Sahl, J. R. Howard · 2007 · Comprehensive Medicinal Chemistry II
66. Patent Rights or Patent Wrongs? The Case of Patent Rights on Aids Drugs
    S. Byrne, Paul Davey, K. McFarlane, John O’Brien, Craig Templeton · 2006
67. Ethical Challenges in Medicine
    M. Rothberg · 2005
68. Who's afraid of biomedicine? Insights, fears, risks and opportunities
    M. Sargent · 2005 · Interdisciplinary Science Reviews
69. OBESITY IN ELDERLY HOSPITALIZED PATIENTS: GRUPPO ITALIANO DI FARMACOVIGILANZA NELL'ANZIANO
    A. Corsonello, C. Pedone, F. Corica, Raffaele Antonelli Incalzi · 2005 · Journal of The American Geriatrics Society
70. Dr Jerome Kassirer’s Book On The Take: How Medicine’s Complicity With Big Business Can Endanger Your Health Worthy of Comment
    T. Ryan, R. Desanctis · 2005
71. Maintaining public trust in medical journals.
    T. Liesegang, A. Schachat, D. Albert · 2005 · American journal of ophthalmology-glaucoma
72. The socio-cultural, economic and political impediments to pain care in the twenty-first century
    Anthony J. Eksterowicz, N. Eksterowicz · 2004 · The Social Science Journal
73. Evidence-based Medicine im psychiatrischen Alltag: ein Plädoyer
    S. Weinmann · 2004
74. Investigators’ responsibilities and rights
    H. Polk, T. Bowden, L. Rikkers, C. Balch, C. Organ, J. Murie, W. Pories, M. Buechler, J. Neoptolemos, V. Fazio et al. · 2002 · Journal of Gastrointestinal Surgery
75. PHARMACOECONOMIC COMPONENT OF A CLINICAL TRIAL CONDUCTED IN LATIN AMERICA
    Daniel Reinharz, V. Saldaña, Wilson Follador, C. Asche · 2001 · International Journal of Technology Assessment in Health Care
76. The FDA and The Lancet: an exchange
    R. Horton · 2001
77. The role of osteoprotegerin and receptor activator of nuclear factor ?B ligand in the pathogenesis and treatment of rheumatoid arthritis
    Lorenz Christian Hofbauer, Armin E. Heufelder · 2001 · Arthritis & Rheumatism
78. Die Industrie und die Ärzteschaft
    E. Gysling · 2000
79. Is JPGN a Scientific or a Medical Journal
    J. Desjeux · 2000
80. What you need to know about clinical research ethics
    E. Derenzo, E. Singer, Joel Moss · 2020 · Ethical Considerations When Preparing a Clinical Research Protocol
81. 'Money Blinding' as a Solution to Biased Design and Conduct of Scientific Research
    Christopher T. Robertson, M. Rodwin · 2016 · Elsevier eBooks
82. Uncloaking Family Medicine Research: So Much To Know, So Little Time . . .
    C. Jaén · 2013 · Journal of the American Board of Family Medicine
83. Industry-Sponsored Clinical Research in Academia
    I. Biaggioni · 2009
84. Dealing with Conflicts of Interest in Biomedical Research: IRB Oversight as the Next Best Solution to the Abolitionist Approach
    J. Goldner · 2000 · Journal of Law, Medicine & Ethics
85. Gene Therapy and Infection Control: More Light on the Way
    L. Strausbaugh · 2000 · Infection Control & Hospital Epidemiology
86. Comparing the Clinical Trial Characteristics of Industry-Funded Trials and Non Industry-Funded Trials
    Emily A. G. Hughes, Tamara Van Bakel, Ashley Raudanskis, Prachi Ray, Benazir H. Hodzic-Santor, Ushma Purohit, Chana A. Sacks, Michael Fralick · 2024 · The Journal of Law Medicine & Ethics
87. Conflict of interest.
    S. Khandpur, P. Pahwa · 2023 · Indian Journal of Dermatology, Venereology and Leprology
88. ETHICS IN MEDICAL RESEARCH AND PUBLISHING
    H. Ghaderi, E. S. Gooshki, E. Kruger · 2022 · Central Asian Journal of Medical Hypotheses and Ethics
89. Privatization of Science – A Silent Phenomenon
    Lidija Gajski · 2019 · Pannoniana
90. Conflicts of Interest in Human Subject Research: The Insufficiency of U.S. and International Standards
    M. Rodwin · 2019 · American Journal of Law & Medicine
91. Pharmacoepidemiology and the Law
    A. Kesselheim, K. N. Vokinger · 2019 · Pharmacoepidemiology
92. Academic Ethos in Physical Therapy Education
    J. Carey · 2019 · Journal of Physical Therapy Education
93. Prescription drug assistance for elderly patients in the emergency department.
    L. Ouellette, R. Halasa, Andrew M. Brown, R. Beckett, D. Patel, T. Chassee, C. Sutliffe, Jeffrey S. Jones · 2019 · American Journal of Emergency Medicine
94. Conflict of interest: a major problem in medical research
    J. Fraser · 2018
95. Establishing a Regional Blockchain Innovation Cluster in Health Care
    Thomas F. Heston · 2017
96. Academic–Industry Research Partnerships: an Emerging Opportunity or Just Smoke and Mirrors?
    M. Hochman, Rachael Bedard · 2016 · Journal of general internal medicine
97. Site Characteristics Influencing the Translation of Clinical Research Into Clinical Practice
    Marie Smed, Kenneth A. Getz · 2014 · Therapeutic Innovation & Regulatory Science
98. Views from Academia, Industry, Regulatory Agencies, and the Legal System
    J. Avorn, Jingping Mo, R. Reynolds, G. Dal Pan, P. Arlett, A. Kesselheim · 2013 · Textbook of Pharmacoepidemiology
99. Information transfer in medicine: modus vivendi out of paradise*
    R. Griebenow, L. Michalis, D. Schulenburg, Robert Schaefer, Heinz Weber · 2013 · Journal of European CME
100. Considerations in the design of clinical trials for erectile dysfunction
     N. Al-hathal, Talal M. Al-Qaoud, S. Carrier · 2012